Attached files
file | filename |
---|---|
EXCEL - IDEA: XBRL DOCUMENT - ENDONOVO THERAPEUTICS, INC. | Financial_Report.xls |
10-Q - HVPA 10-Q 06/30/12 - ENDONOVO THERAPEUTICS, INC. | hpa10q_063012apg2.htm |
EX-32.1 - EXHIBIT 32.1 CERTIFICATION - ENDONOVO THERAPEUTICS, INC. | ex32_1apg.htm |
EX-31.1 - EXHIBIT 31.1 CERTIFICATION - ENDONOVO THERAPEUTICS, INC. | ex31_1apg.htm |
EX-32.2 - EXHIBIT 32.2 CERTIFICATION - ENDONOVO THERAPEUTICS, INC. | ex32_2apg.htm |
Exhibit 31.2
Certification of Principal Financial Officer
Pursuant to 18 U.S.C. 1350
(Section 302 of the Sarbanes-Oxley Act of 2002)
I, Dean S. Skupen, certify that:
1. | I have reviewed this Quarterly Report on Form 10-Q of Hanover Portfolio Acquisitions, Inc.; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrants other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
5. | The registrants other certifying officer and I have disclosed, based on our most recent evaluation, to the registrants auditors and the audit committee of registrants board of directors (or persons performing the equivalent functions): |
| (b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal controls. |
Dated: August 20, 2012 | /s/ Dean S. Skupen |
| Dean S. Skupen, Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) |